跳至主要内容
临床试验/NCT02021487
NCT02021487终止不适用

Pilot Study Prok-Idm: Interest of Dosage of Prokinecitine in Acute Myocardial Infarction

University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 172 人开始时间: 2013年11月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
172
试验地点
1
主要终点
Infarct size by MRI necrotic myocardial mass

研究概览

简要总结

The study aims to investigate the presence of a substance in the blood called prokinecitine, which is released by the heart when a heart attack occurs. Several venous blood samples at the arm are withdrawn at admission, H6, H12, H24, H48 and H72 in order to measure the concentration of this substance in the blood. The usefulness of this new blood marker is going to be determsined to seek if it would be of help to better diagnose or estimate the gravity of heart infarction after a heart attack.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with acute St elevation myocardial infarction of less than 6 hours
  • Age>18 y/o

排除标准

  • Previous myocardial infarction
  • Renal Insuffiency MDRD<30 mL/min
  • Patient with Pace-Maker or ICD.

结局指标

主要结局

Infarct size by MRI necrotic myocardial mass

时间窗: 7 days

Infarct size by MRI necrotic myocardial mass

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Prokinecitine in Acute Myocardial Infarction | 临床试验